Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Longini

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
American Journal of Epidemiology|September 1, 1988
Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents. A field trial in Tecumseh, MichiganI M Longini, A S Monto
International Journal of Epidemiology|March 1, 1991
Measures of the effects of vaccination in a randomly mixing populationM Haber, I M Longini, M E Halloran
Statistics in Medicine|October 11, 1991
Estimation of vaccine efficacy in outbreaks of acute infectious diseasesM Haber, I M Longini, M E Halloran
American Journal of Epidemiology|September 1, 1989
Re: "Use of Modeling in Infectious Disease Epidemiology"I M Longini, M Haber, J S Koopman
Biometrics|March 1, 1988
Models for the statistical analysis of infectious disease dataM Haber, I M Longini, G A Cotsonis
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccinesI M Longini, S Datta, M E Halloran
Mathematical Biosciences|September 1, 1993
Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneityI M Longini, M E Halloran, M Haber
Biometrics|September 11, 1991
A generalized stochastic model for the analysis of infectious disease final size dataC L Addy, I M Longini, M Haber
Biometrics|September 14, 2000
Modeling markers of disease progression by a hidden Markov process: application to characterizing CD4 cell declineC Guihenneuc-Jouyaux, S Richardson, I M Longini
Statistics in Medicine|March 4, 1998
Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacyS Datta, M E Halloran, I M Longini
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
American Journal of Epidemiology|September 1, 1988
Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents. A field trial in Tecumseh, MichiganI M Longini, A S Monto
International Journal of Epidemiology|March 1, 1991
Measures of the effects of vaccination in a randomly mixing populationM Haber, I M Longini, M E Halloran
Statistics in Medicine|October 11, 1991
Estimation of vaccine efficacy in outbreaks of acute infectious diseasesM Haber, I M Longini, M E Halloran
American Journal of Epidemiology|September 1, 1989
Re: "Use of Modeling in Infectious Disease Epidemiology"I M Longini, M Haber, J S Koopman
Biometrics|March 1, 1988
Models for the statistical analysis of infectious disease dataM Haber, I M Longini, G A Cotsonis
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccinesI M Longini, S Datta, M E Halloran
Mathematical Biosciences|September 1, 1993
Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneityI M Longini, M E Halloran, M Haber
Biometrics|September 11, 1991
A generalized stochastic model for the analysis of infectious disease final size dataC L Addy, I M Longini, M Haber
Biometrics|September 14, 2000
Modeling markers of disease progression by a hidden Markov process: application to characterizing CD4 cell declineC Guihenneuc-Jouyaux, S Richardson, I M Longini
Statistics in Medicine|March 4, 1998
Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacyS Datta, M E Halloran, I M Longini
Pageof 7